288 related articles for article (PubMed ID: 16253450)
1. Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model.
Chen CH; Sheu MT; Wu AB; Lin KP; Ho HO
Int J Pharm; 2005 Dec; 306(1-2):91-8. PubMed ID: 16253450
[TBL] [Abstract][Full Text] [Related]
2. Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.
Sheu MT; Wu AB; Lin KP; Shen CH; Ho HO
Drug Dev Ind Pharm; 2006 Jun; 32(5):595-607. PubMed ID: 16720414
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vivo evaluation of lecithin-based microparticles for topical delivery of minoxidil.
Lee HJ; Oh DW; Na MJ; Kim DW; Yuk DY; Choi HC; Lee YB; Han K; Park CW
Arch Pharm Res; 2017 Aug; 40(8):943-951. PubMed ID: 28770536
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the penetration enhancement with the influence of an alcohol/tocopheryl polyethylene glycol succinate (TPGS) cosolvent system on the molecular structure of the stratum corneum of nude mouse skin as examined by microscopic FTIR/DSC.
Liou YB; Ho HO; Chen SY; Sheu MT
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Oct; 74(3):695-703. PubMed ID: 19716337
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
6. Topical minoxidil therapy for hair regrowth.
Rumsfield JA; West DP; Fiedler-Weiss VC
Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
[TBL] [Abstract][Full Text] [Related]
7. Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat.
Tricarico D; Maqoud F; Curci A; Camerino G; Zizzo N; Denora N; Cutrignelli A; Laquintana V; Lopalco A; la Forgia F; Fontana S; Franco M; Lopedota A
Eur J Pharm Biopharm; 2018 Jan; 122():146-157. PubMed ID: 29079420
[TBL] [Abstract][Full Text] [Related]
8. Minoxidil-containing dosage forms: skin retention and after-rinsing hair-growth promotion.
Kim JC; Lee MH; Rang MJ
Drug Deliv; 2003; 10(2):119-23. PubMed ID: 12746058
[TBL] [Abstract][Full Text] [Related]
9. After-rinsing hair growth promotion of minoxidil-containing amino alpha-cyclodextrins.
Kim JC; Kim MD
J Microbiol Biotechnol; 2007 Dec; 17(12):1965-9. PubMed ID: 18167443
[TBL] [Abstract][Full Text] [Related]
10. Topical minoxidil therapy for hereditary male pattern alopecia.
Roenigk HH; Pepper E; Kuruvilla S
Cutis; 1987 Apr; 39(4):337-42. PubMed ID: 3556042
[TBL] [Abstract][Full Text] [Related]
11. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction.
Meephansan J; Thummakriengkrai J; Ponnikorn S; Yingmema W; Deenonpoe R; Suchonwanit P
Arch Dermatol Res; 2017 Nov; 309(9):729-738. PubMed ID: 28884378
[TBL] [Abstract][Full Text] [Related]
13. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs.
Ke WT; Lin SY; Ho HO; Sheu MT
J Control Release; 2005 Feb; 102(2):489-507. PubMed ID: 15653166
[TBL] [Abstract][Full Text] [Related]
14. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.
Barbareschi M
G Ital Dermatol Venereol; 2018 Feb; 153(1):102-106. PubMed ID: 29319278
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
[TBL] [Abstract][Full Text] [Related]
16. D-α-tocopheryl polyethylene glycol 1000 succinate-containing vehicles provide no detectable chemoprotection from oxidative damage.
Baumgart BR; Van Vleet TR; Simic D; Salcedo TW; Lentz K; Donegan M; Davies MH; Bunch RT; Sanderson TP; Lange RW
J Appl Toxicol; 2015 Jul; 35(7):791-8. PubMed ID: 25348750
[TBL] [Abstract][Full Text] [Related]
17. Phase behavior of TPGS-PEG400/1450 systems and their application to liquid formulation: a formulation platform approach.
Li J; Yang B; Levons J; Pinnamaneni S; Raghavan K
J Pharm Sci; 2011 Nov; 100(11):4907-21. PubMed ID: 21656767
[TBL] [Abstract][Full Text] [Related]
18. Topical tretinoin for hair growth promotion.
Bazzano GS; Terezakis N; Galen W
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):880-3, 890-3. PubMed ID: 3771854
[TBL] [Abstract][Full Text] [Related]
19. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
Olsen EA; Weiner MS
J Am Acad Dermatol; 1987 Jul; 17(1):97-101. PubMed ID: 3301926
[TBL] [Abstract][Full Text] [Related]
20. Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss.
McCoy J; Kovacevic M; Situm M; Stanimirovic A; Bolanca Z; Goren A
J Biol Regul Homeost Agents; 2016; 30(1):131-4. PubMed ID: 27049083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
